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March 5, 2013:985–911.15 (1.08 to 1.22), 1.53 (1.42 to 1.64), and 1.40 (1.33 to 1.48),
respectively. In the multivariate model adjusted for age, sex,
comorbid risk, and concomitant diuretics and beta-blockers, statin
therapy was independently associated with the risk of diabetes
occurrence (hazard ratio: 1.13 [95% confidence interval: 1.07 to
1.20], p  0.001).
Statin therapy has been associated with excessive occurrence of
diabetes in subjects with unfavorable metabolic profiles (4,5).
Beyond that, it is particularly important to investigate whether the
risk would be further amplified by the concomitant treatment
targeting those factors to decide the treatment matrix for future
patients.
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Slimming the Heart
With Bariatric Surgery
We read with interest the paper by Gaborit et al. (1) describing the
effects of bariatric surgery on epicardial fat and myocardial triglyc-
eride content (MTGC). One of the authors’ main conclusions is
that a reduction in epicardial fat may be partially responsible for
the decrease in cardiac mortality observed after successful weight-
loss surgery because ectopic cardiac fat releases inflammatory
mediators and free fatty acids into the vasculature (1). The study
also demonstrates a decrease in systemic insulin resistance and
improvement in diastolic function after bariatric surgery. We have
made similar observations (2–4) and wish to offer a somewhat
different interpretation, which should complement the authors’
well-designed study. In patients with clinically severe obesity and
insulin resistance, we observed a negative association between the
plasma levels of long-chain free fatty acids and diastolic function
and suggest that excess free fatty acids exert lipotoxic effects on the
heart, leading to impairment in intracellular calcium cycling andcardiac function (2). Thus, one may reasonably conclude that the
improvement in cardiac function after bariatric surgery is directly
related to a decrease in lipotoxicity. However, no considerable
change in MTGC was appreciated in the authors’ study through
the use of magnetic resonance spectroscopy despite a statistically
significant decrease in epicardial fat and serum triglyceride levels.
One plausible explanation involves the modality used in the
measurement of MTGC. The practical method used to determine
MTGC is a conventional technique known as voxel positioning in
the ventricular septum to avoid contamination from epicardial fat
and lessen the degree of artifact from cardiac motion. Nonetheless,
the distribution of triglycerides in the human heart is heteroge-
neous in nature; thus, the conventional approach does not correlate
well with overall cardiac steatosis (5).
After successful bariatric surgery, our studies also show a
remarkable decrease in increased plasma free fatty acid levels, as
well as improved derangements in muscle metabolism and cardiac
function (3). Moreover, even as other hallmarks of obesity, such as
insulin resistance, free fatty acid levels, body composition, and
body mass index, have a tendency to plateau postoperatively, the
benefits of successful weight-loss surgery on left ventricular mass
are sustained and show a linear decrease over a 2-year period (4).
In short, our earlier work adds to the authors’ remarkable study
on the effects of weight loss after bariatric surgery on cardiac
function. We propose that by targeting the source of excess energy,
weight-loss surgery reduces left ventricular mass and improves
overall cardiac function by limiting the substrate supply to a
metabolically overloaded heart (6). The decrease in epicardial fat
volume after weight loss likely plays a key role in decreasing fatty
acid fuel to the heart, further reducing lipotoxicity. There is much
more to be gained from this fascinating area of research.
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Reply
We read with interest the letter by Drs. Khalaf and Taegtmeyer
(1), which nicely emphasizes the importance of research on
thinning the heart with bariatric surgery (BS). Improvement of
cardiac function after BS has been widely described, but Taegt-
meyer’s group (2) has remarkably shown that left ventricular (LV)
mass continues to improve 24 months after surgery, whereas body
mass index (BMI) and metabolic parameters have started to
plateau. We agree that the regression of cardiac abnormalities after
BS is complex, sequential, and of a multifactorial nature. The
chronological sequence of events after BS is thus crucial to
examine. We and others (3) have previously shown that one of the
first events after surgery is the improvement of the adipose tissue
inflammatory pattern, which in turn may contribute to reduced
muscular and heart insulin resistance. This decrease in low-grade
inflammation could be partly linked to the rapid adaptation of gut
microbiota to starvation and weight loss (4). This rapid decrease in
inflammation and insulin resistance is associated 3 months after
surgery with a favorable change in LV function, whereas BMI is
still very high (5). The increase in incretin levels and particularly
glucagon-like peptide 1 may also participate in the improvement of
endothelial function and cardiac parameters. Although the meta-
bolic and hormonal shifts are very sudden, the impact of weight
loss on sympathetic tone and sleep apnea is more gradual and may
be involved in the sustained recovery of cardiac function. We agree
that the lack of a decrease in myocardial triglyceride content
(MTGC) 6 months after surgery was unexpected, which suggests
that MTGC is not the sole mediator of cardiac function recovery.
As the imbalance between fatty acid uptake and oxidation leads to
accumulation of intramyocellular triglycerides, one should reason-
ably expect that the decrease in free fatty acid (FFA) supply would
lead to a decrease in MTGC. However, according to the “starva-
tion theory,” a persistent lack of FFA supply in a previously
overloaded heart may initially trigger mechanisms of energy
preservation, protecting the heart against a lack of energy substrate
and preventing it from removing intracellular lipid storage. An
alternative explanation would be that a more prolonged weight loss
is required to change MTGC to a measurable extent and that our
assessment was too early. Indeed, the decrease in intramuscularlipid content was previously shown to occur at later time points and
reach significance only after 9 months (5). Regarding the hetero-
geneity of cardiac steatosis proposed by Khalaf et al. and the
position of the voxel used in our study (interventricular septum),
we intentionally chose this location because it is distant from
epicardial fat. Moreover, Liu et al. (6), as cited by Khalaf et al. (1),
recently demonstrated that septal fat is representative of a mean
myocardial fat percentage.
To summarize, further cinetic studies with long-term follow-up
are needed to evaluate the sequence of ectopic fat storage and
removal after bariatric surgery.
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